Summary of equity attributable to Novartis AG shareholders (Details 2) Pure in Millions, $ in Billions |
1 Months Ended | 6 Months Ended | |
|---|---|---|---|
|
Jul. 31, 2023
USD ($)
|
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Disclosure of classes of share capital [line items] | |||
| Maximal amount of share buyback programm | $ 15.0 | ||
| Number of shares to be repurchased | 10.7 | 8.7 | |